Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)
The purpose of this study is to compare and determine the efficacy of combined metformin and Clomiphene citrate administration to that of laparoscopic ovarian diathermy (LOD) in infertile women with Polycystic ovary syndrome (PCOS) not responding to treatment with Clomiphene alone.
Polycystic Ovary Syndrome
DRUG: metformin HCl (Cidophage速; CID,Cairo, Egypt), CC (Clomid速; Global Napi Pharmaceuticals,Cairo, Egypt),Cairo, Egypt)|PROCEDURE: Laparoscopic ovarian diathermy (LOD)
occurrence of ovulation and midcycle endometrial thickness (mm).
occurrence of pregnancy, miscarriage, multiple pregnancy and live birth rates.
All patients in the combined metformin-CC group received metformin HCl (Cidophage速;Chemical Industries Development,Cairo, Egypt), 500 mg thrice daily for 6-8 weeks. Then after the end of this period, they received 100 mg CC (Clomid速; Global Napi Pharmaceuticals,Cairo, Egypt) for 5 days starting from day 3 of menstruation (increased by 50 mg in the next cycle in case of anovulation ). Patients continued treatment for up to six cycles. Metformin was stopped only when pregnancy was documented. All patients in the control group underwent laparoscopic ovarian diathermy, then followed up for 6 months.